Access issues due to cost and availability causes disparities in biologics use; cancer risk is minimal and there is much more on the horizon for hidradenitis suppurativa, researchers say at AAD 2018.
Modern medicine – dermatology
Tag Archives: cons
CAR T-cell therapies in treating lymphoma: Pros and cons
Catherine Bollard, MD, discusses the success rate of CAR T-cell treatments, remaining obstacles, and top payer considerations.
Managed Healthcare Executive – Health Management